Results 191 to 200 of about 130,661 (316)

The use of tacrolimus (FK506) and antimetabolites as immunosuppressants for xenotransplantation across closely related rodent species [PDF]

, 1997
Demetris, AJ, Fung, JJ, Murase, N, Rao, AS, Starzl, TE, Valdivia, LA   +5 more
core  

A Prospective Randomised Paired Trial of Sirolimus versus Tacrolimus as Primary Immunosuppression following Non-Heart Beating Donor Kidney Transplantation

, 2014
John Asher, Nikhil Vasdev, H. Wyrley-Birch, Colin Wilson, Naeem Soomro, D. Rix, Bryon Jaques, Derek Manas, Nicholas Torpey, David Talbot   +9 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Impact of High Tacrolimus Exposure on Graft Function and Development of a Prediction Model in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study. [PDF]

Drug Des Devel Ther
Yang W, Xia R, Zhao P, Du J, Liu R, Zeng W, Chen Y, Luo X, Zheng P, Li Y, Mo L.   +10 more
europepmc   +1 more source

Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients [PDF]

Tara B. Gavcovich, Vaka K. Sigurjonsdottir, Marissa J. DeFreitas, Claudia Serrano, Eva Rivas, Marília Formentini Scotton Jorge, Wacharee Seeherunvong, Chryso Katsoufis, Wendy Glaberson, Melisa Oliva, Adela Mattiazzi, Carolyn Abitbol, Jayanthi Chandar   +12 more
openalex   +1 more source

Tacrolimus ointment in the treatment of hormone-dependent dermatitis

, 2020
Mao Li, Wen‐Hann Tan, Jingjing Du, Qiuyue Wang, Linyue Wang, Min Lei, Pingsheng Hao   +6 more
openalex   +1 more source

Sensitivity of Whole-Blood T Lymphocytes in Individual Patients to Tacrolimus (FK 506): Impact of Interleukin-2 mRNA Expression as Surrogate Measure of Immunosuppressive Effect [PDF]

, 2004
Christoph Härtel, Nina Schumacher, Lutz Fricke, Brigitte Ebel, Holger Kirchner, Michael Müller‐Steinhardt   +5 more
openalex   +1 more source

Wells syndrome: clinical findings and management in a large cohort of 48 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa, Silvia Robuffo, Tullio Brunetti, Luca Rapparini, Bianca Maria Piraccini, Cosimo Misciali, Beatrice Raone, Iria Neri, Federica Filippi   +8 more
wiley   +1 more source

Impact of cytochrome P450 3A5 expression on clinical outcomes in renal transplant recipients receiving tacrolimus-based immunosuppression. [PDF]

World J Transplant
Pasari AS, Malde S, Tolani P, Ramteke V, Gupta S, Pawar T, Jeyachandran V, Sejpal K, Kurundwadkar M, Gurjar P, Kashiv P, Dubey S, Bawankule C, Kute VB, Deshpande N, Balwani MR.   +15 more
europepmc   +1 more source

Tacrolimus (FK506) and therapy of human autoimmune disorders [PDF]

, 1996
Abu-Elmagd, K, Carroll, PB, Irish, W, McCauley, J, McMichael, J, Rilo, HR, Starzl, TE, Thomson, AW, Van Thiel, DH   +8 more
core